Dong-A Socio Holdings Co., Ltd. (KRX:000640)
121,000
-900 (-0.74%)
At close: Dec 5, 2025
Dong-A Socio Holdings Revenue
Dong-A Socio Holdings had revenue of 382.60B KRW in the quarter ending September 30, 2025, with 7.20% growth. This brings the company's revenue in the last twelve months to 1.40T, up 9.02% year-over-year. In the year 2024, Dong-A Socio Holdings had annual revenue of 1.33T with 17.78% growth.
Revenue (ttm)
1,404.83B
Revenue Growth
+9.02%
P/S Ratio
0.55
Revenue / Employee
16.93B
Employees
5,653
Market Cap
778.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,333.23B | 201.23B | 17.78% |
| Dec 31, 2023 | 1,132.00B | 117.14B | 11.54% |
| Dec 31, 2022 | 1,014.86B | 132.92B | 15.07% |
| Dec 31, 2021 | 881.94B | 98.63B | 12.59% |
| Dec 31, 2020 | 783.32B | 13.63B | 1.77% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| Peptron | 6.19B |